arbiter
JournalsPricingAccount

The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics

Lorenzo Martellone et al.

Applied Health Economics and Health Policy2026https://doi.org/10.1007/s40258-026-01032-8article
AJG 1ABDC C
Weight
0.50

What the paper says

The Italian system has been applied consistently over time, with appraisal outcomes largely reflecting the formal decision criteria rather than regulatory status. The 2025 reform may represent a turning point, potentially changing designation patterns and their determinants. Ongoing monitoring is needed to ensure access does not compromise evidence standards or sustainability, offering lessons that may be relevant to other health systems considering similar mechanisms.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1007/s40258-026-01032-8

Or copy a formatted citation

@article{lorenzo2026,
  title        = {{The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics}},
  author       = {Lorenzo Martellone et al.},
  journal      = {Applied Health Economics and Health Policy},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1007/s40258-026-01032-8},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.